4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000079
SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $109.27 ($546,353)
- SVP, GEN COUNSEL & CORP SEC acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-10-07 | Option exercise 10b5-1 | +5,000 | $21.41 | $107,050 | 33,623 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-10-07 | Sale 10b5-1 | −476 | $107.51 | $51,175 | 33,147 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-10-07 | Sale 10b5-1 | −996 | $108.69 | $108,252 | 32,151 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-10-07 | Sale 10b5-1 | −3,147 | $109.55 | $344,744 | 29,004 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-10-07 | Sale 10b5-1 | −314 | $110.51 | $34,699 | 28,690 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-10-07 | Sale 10b5-1 | −67 | $111.68 | $7,483 | 28,623 | D |
| Derivatives | |||||||
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-10-07 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 169,497 | D | ||
| Open-market sales · 5,000 sh · avg $109.27 · $546,353 | |||||||
Loading xslF345X05/wk-form4_1728433783.xml…